1. Precision medicine for cancer patients: worth a special issue

   • Klaus Höffken

   Editorial 13 January 2023 Pages: 1 - 1

2. Quo vadis precision oncology?

   • Kathrin Heinrich
   • C. Benedikt Westphalen

   Guest Editorial Open access 13 January 2023 Pages: 3 - 4

3. Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis

   • Chi-Lu Chiang
   • Hsiang-Ling Ho
   • Teh-Ying Chou

   Research 01 November 2022 Pages: 5 - 14

   

4. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)

   • Lizong Wang
   • Yi Cao
   • Jingyun Xu

   Research Open access 29 September 2022 Pages: 15 - 24

   

5. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review

   • Pandu P. Nugroho
   • Siti Alyaa S. Ghozali
   • Jeanette C. Reece

   Research Open access 17 October 2022 Pages: 25 - 46

   

6. Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes

   • Chenggong Ma
   • Yunong Bao
   • Hui Li

   Research 18 December 2022 Pages: 47 - 62

   

7. RETRACTED ARTICLE: The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis)

   • Oksana Movchan
   • Valentin Svintsitskyi

   Research 11 October 2022 Pages: 63 - 68

   

8. Mutational profiles of head and neck squamous cell carcinomas based upon human papillomavirus status in the Veterans Affairs National Precision Oncology Program

   • Steven Doerstling
   • David Winski
   • Vishal Vashistha

   Research 18 September 2022 Pages: 69 - 77

   

9. HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways

   • Yi Ding
   • Shida Xiong
   • Ju Guo

   Research 14 November 2022 Pages: 79 - 90

   

10. Computer-aided detection and prognosis of colorectal cancer on whole slide images using dual resolution deep learning

    • Yan Xu
    • Liwen Jiang
    • Jiangyu Zhang

    Research 04 November 2022 Pages: 91 - 101

    

11. A single-center experience with linear accelerator-based stereotactic radiotherapy for meningiomas: hypofractionation and radiosurgery

    • Ahmed Gawish
    • Nurlan Abdulayev
    • Thomas B. Brunner

    Research Open access 28 October 2022 Pages: 103 - 109

    

12. Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment

    • Marie-Therese Forster
    • Marion Hug
    • Joachim P. Steinbach

    Research Open access 08 November 2022 Pages: 111 - 119

    

13. miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/β-catenin signaling pathway

    • Lin Li
    • Pengwei Liu
    • Chunfang Xu

    Research 10 November 2022 Pages: 121 - 134

    

14. A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer

    • Jinggao Feng
    • Xiayu Tang
    • Yao Huang

    Research 05 November 2022 Pages: 135 - 146

    

15. The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2

    • Zahraa K. Lawi
    • Mohammed Baqur S. Al-Shuhaib
    • Ibtissem Ben Amara

    Research 01 September 2022 Pages: 147 - 157

    

16. Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

    • Green Hong
    • Pureum Sun
    • Da Hyun Kang

    Research Open access 06 December 2022 Pages: 159 - 171

    

17. Diagnostic, prognostic, and immunological roles of CD177 in cervical cancer

    • Wenxin Liao
    • Wei Li
    • Fujin Shen

    Research 09 November 2022 Pages: 173 - 189

    

18. Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma

    • Xiaofei Yuan
    • Huiru Feng
    • Fan Wang

    Research Open access 03 January 2023 Pages: 191 - 202

    

19. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer

    • Xu Jiang
    • Jing Ke
    • Wei Yuan

    Research 14 November 2022 Pages: 203 - 218

    

20. Curcumin combined with arsenic trioxide in the treatment of acute myeloid leukemia: network pharmacology analysis and experimental validation

    • Ying-jian Zeng
    • Fan Liu
    • Zhen-hui Wu

    Research 09 November 2022 Pages: 219 - 230

    

21. Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma

    • Qilin Tang
    • Deshen Pan
    • Lei Chen

    Research 20 November 2022 Pages: 231 - 245

    

22. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC

    • Meng Wang
    • Liu Liu
    • Gang Huang

    Research Open access 24 December 2022 Pages: 247 - 261

    

23. Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma

    • Jiaqi Huang
    • Chenchen Dai
    • Hang Wang

    Research 15 December 2022 Pages: 263 - 270

    

24. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144

    • Ioannis Pozios
    • Nina A. Hering
    • Hendrik Seeliger

    Research Open access 10 December 2022 Pages: 271 - 280

    

25. Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds

    • Shun Wan
    • Jinlong Cao
    • Li Yang

    Research 23 December 2022 Pages: 281 - 296

    

26. Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo

    • M. Houweling
    • U. K. Abdul
    • B. A. Westerman

    Research 01 December 2022 Pages: 297 - 305

    

27. Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma

    • Qixuan Li
    • Yijie Tang
    • Jiahai Shi

    Research 28 December 2022 Pages: 307 - 323

    

28. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches

    • Reyhaneh Aghayousefi
    • Seyed Mahdi Hosseiniyan Khatibi
    • Mohammad Teshnehlab

    Research 15 November 2022 Pages: 325 - 341

    

29. Genome-wide DNA methylation profile analysis identifies an individualized predictive signature for melanoma immune response

    • Junya Yan
    • Xiaowen Wu
    • Shundong Cang

    Research 03 January 2023 Pages: 343 - 356

    

30. Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors

    • Jing Yang
    • Jiali Hou
    • Mengxia Li

    Review 12 October 2022 Pages: 357 - 366

    

31. Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents

    • Disha Shah
    • Ajazuddin
    • Sankha Bhattacharya

    Review 21 October 2022 Pages: 367 - 391

    

32. Role of smartphone devices in precision oncology

    • Ruby Srivastava

    Review 17 October 2022 Pages: 393 - 400

    

33. Long non-coding RNAs involved in retinoblastoma

    • Ava Nasrolahi
    • Shirin Azizidoost
    • Mostafa Feghhi

    Review 28 October 2022 Pages: 401 - 421

    

34. Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options

    • Qiuxing Meng
    • Yaoming Deng
    • Shifu Tang

    Review 15 November 2022 Pages: 423 - 439

    

35. Implication of gut microbes and its metabolites in colorectal cancer

    • Arun Kumar
    • Asgar Ali
    • Sundeep Singh Saluja

    Review 27 December 2022 Pages: 441 - 465

    

36. Predictive biomarkers in gastric cancer

    • C. Röcken

    Review Open access 19 October 2022 Pages: 467 - 481

    

37. The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection

    • Jinjing Xu
    • Kuiyang Zhu
    • Jing Chen

    Review 31 October 2022 Pages: 483 - 501

    

38. Applications of artificial intelligence multiomics in precision oncology

    • Ruby Srivastava

    Review 07 July 2022 Pages: 503 - 510

    

39. Understanding the regulation of “Don’t Eat-Me” signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy

    • Ashkan Zare Karizak
    • Zahra Salmasi
    • Amir Savardashtaki

    Review 07 November 2022 Pages: 511 - 529

    

40. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis

    • Meiya He
    • Nan Jiang
    • Ketao Mu

    Review 19 November 2022 Pages: 531 - 540

    

41. Gut microbiota: a potential target for improved cancer therapy

    • Mingkuan Zhao
    • Gen Jiang
    • Jie Zhou

    Review 23 December 2022 Pages: 541 - 552